A simple daily pill could stop Parkinson's disease before it starts
Key Points:
- Australian researchers have developed a daily pill that reduces brain inflammation in individuals showing early warning signs of Parkinson’s disease, potentially halting the disease before symptoms appear.
- In a trial involving 41 participants, brain scans revealed decreased inflammation in the movement control area after several weeks of treatment.
- Current Parkinson’s treatments only address symptoms, but this experimental drug offers hope for slowing or preventing the disease by protecting brain cells from dying.
- Experts emphasize the need for longer, more extensive trials to confirm the drug’s effectiveness in preventing Parkinson’s, with additional funding required for further research.
- Parkinson’s affects over 150,000 Australians, with numbers expected to triple by 2050, highlighting the urgent need for breakthroughs like this to provide hope for patients and their families.